Welcome to our dedicated page for Univ Health Svc SEC filings (Ticker: UHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Universal Health Services, Inc. filings document the financial results, governance practices and capital structure of a healthcare-services company operating acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points through subsidiaries. Form 8-K reports include operating and financial results, material agreements, credit-facility disclosures and other corporate events.
UHS proxy materials cover shareholder voting matters, board oversight, executive compensation and incentive-plan arrangements. The company’s regulatory disclosures also address risk factors, legal proceedings, ownership and governance matters, and capital actions such as share repurchases, dividends and financing arrangements.
Form 144 notice: A proposed sale of 3,817 shares of common stock is disclosed. The filing lists an aggregate market value of $852,342.97 and names Morgan Stanley Smith Barney LLC Executive Financial Services as broker. The approximate sale date is 11/11/2025 on the NYSE.
The shares were acquired on 11/11/2025 via a stock option exercise from the issuer, paid in cash on the same date. Shares outstanding were 6,574,600 as shown in the table; this is a baseline figure, not the amount being sold.
Universal Health Services (UHS): Director stock activity reported. On 11/11/2025, a UHS director exercised options for 10,000 Class B shares at $138.8 per share (code M). The filing shows subsequent dispositions: 6,183 shares (code F) at $224.49, sales of 3,675 shares at a weighted average price of $223.2766 (code S; multiple trades between $222.92–$223.91), and 142 shares at a weighted average price of $223.9563 (code S; trades between $223.93–$223.99).
Following these transactions, the director directly owned 8,481 Class B shares. The option covering 10,000 shares (expiring 03/16/2026) now has 0 derivative securities remaining after exercise.
Universal Health Services (UHS) reported stronger third‑quarter results. Net revenues were $4,495,245,000, up from $3,963,027,000 a year ago. Income from operations rose to $521,688,000 from $384,165,000. Net income attributable to UHS increased to $372,957,000, and diluted EPS was $5.86 versus $3.80 last year, reflecting improved operating performance across the business.
For the first nine months of 2025, net revenues reached $12,878,781,000 and diluted EPS was $16.07. The balance sheet showed total assets of $15,343,924,000, cash and cash equivalents of $112,895,000, and total debt carrying value of about $4.7 billion. Near‑term liquidity includes a revolving credit facility with approximately $965 million of available capacity as of September 30, 2025. Current maturities of long‑term debt were $740,186,000, highlighting upcoming obligations. Operating cash flow for the nine months was $1,289,704,000, funding $733,932,000 of capital additions and $615,941,000 of share repurchases.
Universal Health Services (UHS) reported an insider equity transaction by Executive Vice President Matthew J. Peterson. On 10/29/2025, he exercised options for 8,425 Class B shares at $138.8 and 9,465 shares at $152.68 (transaction code M), converting derivatives into common stock.
To satisfy tax obligations, 14,312 shares were withheld at $225.15 (code F). Following these transactions, he directly owned 19,957.5817 Class B shares. The options exercised had vested ratably on 3/17/2022, 3/17/2023, 3/17/2024, and 3/17/2025, and 0 derivative securities remained after the transactions. Holdings include 583.5817 shares acquired through the company’s 2005 Employee Stock Purchase Plan.
Universal Health Services (UHS) director Elliot J. Sussman, M.D., reported insider transactions. On 10/29/2025, he exercised 2,500 options at $138.80 per share (code M), satisfied taxes through the withholding of 1,535 shares at $226.15 (code F), and sold 965 shares at a weighted average price of $225.6981 (code S).
Following these transactions, his directly held Class B common shares were 6,113. The sale price reflects multiple trades between $225.38 and $225.80 as disclosed.
Universal Health Services (UHS) reported insider transactions by President and CEO Marc D. Miller. On 10/29/2025, he exercised options for 75,000 Class B shares at $138.8 and 90,000 Class B shares at $152.68 (code M). Shares totaling 131,758 were withheld to cover taxes at $225.3 (code F).
After these transactions, Miller directly owned 311,296 Class B shares. He also reported indirect holdings through several family trusts, including stakes in the Abby Danielle Miller 2002 Trust, Abby Miller King 2011 Family Trust, Marc Daniel Miller 2002 and 2011 Family Trusts, and Marni Spencer 2002 and 2011 Family Trusts.
Universal Health Services (UHS) reported insider activity by Executive Chairman, Director and 10% Owner Alan B. Miller. On 10/29/2025, he exercised options (code M) to acquire 70,213 Class B shares at $152.68 and 62,500 Class B shares at $138.8. He also disposed of 105,519 Class B shares (code F) at $227.04.
Following these transactions, Miller directly owned 1,746,031 Class B shares. The filing also lists indirect holdings across several entities, including 55,763 shares by The Abby Miller King 2011 Family Trust and 59,900 shares by The Marc Daniel Miller 2011 Family Trust. The options referenced carry an expiration date of 03/16/2026. The report notes a disclaimer of beneficial ownership for certain indirect holdings.
Universal Health Services (UHS) filed a Form 144 notice for a proposed sale of up to 965 shares of common stock with an aggregate market value of $217,798.67. The filing lists Morgan Stanley Smith Barney LLC as broker and the NYSE as the exchange, with an approximate sale date of 10/29/2025.
The securities were acquired via a stock option exercise paid in cash on 10/29/2025. Shares outstanding were 63,638,690.
Universal Health Services (UHS) furnished an Item 2.02 update, stating it issued a press release on October 27, 2025 regarding results of operations and financial condition. The release is attached as Exhibit 99.1.
The filing also lists the Cover Page Interactive Data File as Exhibit 104 and confirms UHS’s Class B common stock trades on the NYSE under the symbol UHS.
Universal Health Services, Inc. reports that its wholly owned administrative services subsidiary, UHS of Delaware, Inc., has received an adverse jury verdict in a Nevada lawsuit related to physician departures from St. Mary’s Medical Group in Reno to Pinnacle Medical Group.
The jury awarded approximately $4.7 million in compensatory damages against UHS of Delaware, Inc. and other defendants, and $500 million in punitive damages against UHS of Delaware, Inc., with lesser punitive amounts against some other defendants. The company states that, based on Nevada statutory law, it expects the punitive damages to be reduced to a maximum of approximately $14 million, and notes that recent Nevada Supreme Court precedent could further reduce the punitive amount.
UHS of Delaware, Inc. and the other defendants are evaluating legal options and intend to challenge the verdict in post-judgment proceedings and on appeal. The company states it is uncertain about its ultimate financial exposure and warns that if it cannot reverse the verdict, significantly reduce damages, or if it must post a substantial bond pending appeal, the matter could have a material adverse effect on its financial condition.